Studies have demonstrated that isoorientin reduces oligomeric Aβ in the hippocampus and cortex and alleviates synaptic dysfunction and spatial memory deficits in APP/PS1 mice; therefore, it has potential therapeutic efficacy in AD [40,41]. The gene discussed is APP; the disease is Alzheimer disease.